Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. 海报 Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. Certara2019 年 9 月 3 日
Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Poster Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Certara2019 年 9 月 3 日
Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug Poster Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug Certara2019 年 9 月 3 日
Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework Poster Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework Certara2019 年 9 月 3 日
Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy Poster Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy Certara2019 年 9 月 3 日
Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect Poster Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect Certara2019 年 9 月 3 日
Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally Poster Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally Certara2019 年 9 月 3 日
Prediction of Plasma, Tissue and in vitro Cell Exposure of CS4 Chemicals Using IVIVE-PBPK and Biokinetic Models Poster Prediction of Plasma, Tissue and in vitro Cell Exposure of CS4 Chemicals Using IVIVE-PBPK and Biokinetic Models Certara2019 年 9 月 3 日
Fasted and Fed State Pancreatic Juice Secretion in the Caucasian Population: A Meta-analysis Poster Fasted and Fed State Pancreatic Juice Secretion in the Caucasian Population: A Meta-analysis Certara2019 年 9 月 3 日
Development of the dermal absorption model for the ketoprofen local and systemic exposure prediction Poster Development of the dermal absorption model for the ketoprofen local and systemic exposure prediction Certara2019 年 9 月 3 日